Literature DB >> 24299689

Exploring issues in difficult-to-treat hypertension.

Michael A Weber1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24299689      PMCID： PMC8033892          DOI： 10.1111/jch.12219

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  47 in total

Review 1.  Clinical inertia.

Authors:  L S Phillips; W T Branch; C B Cook; J P Doyle; I M El-Kebbi; D L Gallina; C D Miller; D C Ziemer; C S Barnes
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

Review 2.  Resistant hypertension.

Authors:  Norman M Kaplan
Journal:  J Hypertens       Date:  2005-08       Impact factor: 4.844

3.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

4.  Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study.

Authors:  Mary J Roman; Richard B Devereux; Jorge R Kizer; Elisa T Lee; James M Galloway; Tauqeer Ali; Jason G Umans; Barbara V Howard
Journal:  Hypertension       Date:  2007-05-07       Impact factor: 10.190

5.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

6.  24-hour efficacy and safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudy.

Authors:  Joseph L Izzo; Steven G Chrysant; Dean J Kereiakes; Thomas Littlejohn Iii; Suzanne Oparil; Michael Melino; James Lee; Victor Fernandez; Reinilde Heyrman
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-10-28       Impact factor: 3.738

7.  Renal denervation revisited: promising treatment for resistant hypertension?

Authors:  Debbie L Cohen; Raymond R Townsend
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-12       Impact factor: 3.738

8.  Ambulatory blood pressure monitoring in patients with chronic kidney disease and resistant hypertension.

Authors:  Salman Shafi; Erdal Sarac; Huy Tran
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-06-20       Impact factor: 3.738

9.  Are sleep symptoms predictors of resistant hypertension in a population-based sample? Findings from the National Health and Nutritional Examination Survey.

Authors:  Harneet Walia; Kingman Strohl; Brian Koo; Andreea Seicean; Sinziana Seicean
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-18       Impact factor: 3.738

10.  Safety and efficacy of aliskiren/amlodipine/hydrochlorothiazide triple combination in patients with moderate to severe hypertension: a 54-week, open-label study.

Authors:  Alexander V Murray; Wolfgang Koenig; Juan Garcia-Puig; Samir Patel; Alkaz Uddin; Jack Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-28       Impact factor: 3.738
View more
  2 in total

1.  Hypertension guidances published in 2013: a busy year with more to follow.

Authors:  J Rick Turner; Snehal Kothari
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03-19       Impact factor: 3.738

2.  Factors associated with components of arterial pressure among older individuals (the multinational MEDIS study): the role of the Mediterranean diet and alcohol consumption.

Authors:  Stefanos Tyrovolas; Josep Maria Haro; Evangelos Polychronopoulos; Anargiros Mariolis; Suzanne Piscopo; Giuseppe Valacchi; Kornilia Makri; Akis Zeimbekis; Dimitra Tyrovola; Vassiliki Bountziouka; Efthimios Gotsis; George Metallinos; Yannis Katsoulis; Josep-Antoni Tur; Antonia Matalas; Christos Lionis; Demosthenes Panagiotakos
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-07-24       Impact factor: 3.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.